BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27465399)

  • 1. Short telomere length and its correlation with gene mutations in myelodysplastic syndrome.
    Hwang SM; Kim SY; Kim JA; Park HS; Park SN; Im K; Kim K; Kim SM; Lee DS
    J Hematol Oncol; 2016 Jul; 9(1):62. PubMed ID: 27465399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of Telomere Lengths and Telomerase Activity in Myelodysplastic Syndrome.
    Park HS; Choi J; See CJ; Kim JA; Park SN; Im K; Kim SM; Lee DS; Hwang SM
    Ann Lab Med; 2017 May; 37(3):195-203. PubMed ID: 28224765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomere dynamics in myelodysplastic syndrome determined by telomere measurement of marrow metaphases.
    Sashida G; Ohyashiki JH; Nakajima A; Sumi M; Kawakubo K; Tauchi T; Ohyashiki K
    Clin Cancer Res; 2003 Apr; 9(4):1489-96. PubMed ID: 12684424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere shortening associated with increased genomic complexity in chronic lymphocytic leukemia.
    Dos Santos P; Panero J; Palau Nagore V; Stanganelli C; Bezares RF; Slavutsky I
    Tumour Biol; 2015 Nov; 36(11):8317-24. PubMed ID: 26008147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomere length and its correlation with gene mutations in chronic lymphocytic leukemia in a Korean population.
    Song DY; Kim JA; Jeong D; Yun J; Kim SM; Lim K; Park SN; Im K; Choi S; Yoon SS; Lee DS
    PLoS One; 2019; 14(7):e0220177. PubMed ID: 31335885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of critically short telomere in myelodysplastic syndrome.
    Shin DY; Lim KM; Park HS; Kwon S; Yoon SS; Lee DS
    Biomark Res; 2022 Nov; 10(1):79. PubMed ID: 36357941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemia arising from MDS: a marker of disease prognosis?
    Sieglová Z; Zilovcová S; Cermák J; Ríhová H; Brezinová D; Dvoráková R; Marková M; Maaloufová J; Sajdová J; Brezinová J; Zemanová Z; Michalová K
    Leuk Res; 2004 Oct; 28(10):1013-21. PubMed ID: 15289012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of flow cytometry-fluorescence in situ hybridization in the measurement of relative telomere length of bone marrow CD34(+) cells in patients with myelodysplastic syndrome].
    Guo TJ; Sun WL; Zhang W; Ma XC; Liu CY; He JJ; Xu J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1195-9. PubMed ID: 24156433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups.
    Gadji M; Adebayo Awe J; Rodrigues P; Kumar R; Houston DS; Klewes L; Dièye TN; Rego EM; Passetto RF; de Oliveira FM; Mai S
    Clin Cancer Res; 2012 Jun; 18(12):3293-304. PubMed ID: 22539801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS).
    Mohamedali AM; Gäken J; Ahmed M; Malik F; Smith AE; Best S; Mian S; Gaymes T; Ireland R; Kulasekararaj AG; Mufti GJ
    Leukemia; 2015 Sep; 29(9):1928-38. PubMed ID: 25943179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere length in myelodysplastic syndromes.
    Rollison DE; Epling-Burnette PK; Park JY; Lee JH; Park H; Jonathan K; Cole AL; Painter JS; Guerrier M; Meléndez-Santiago J; Fulp W; Komrokji R; Lancet J; List AF
    Leuk Lymphoma; 2011 Aug; 52(8):1528-36. PubMed ID: 21635204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of telomere capture in myelodysplastic syndromes.
    Labib HA; Elshorbagy S; Elantonuy NG
    Med Oncol; 2014 Oct; 31(10):216. PubMed ID: 25195039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere shortening and chromosomal instability in myelodysplastic syndromes.
    Lange K; Holm L; Vang Nielsen K; Hahn A; Hofmann W; Kreipe H; Schlegelberger B; Göhring G
    Genes Chromosomes Cancer; 2010 Mar; 49(3):260-9. PubMed ID: 19998444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of telomere length testing in a hospital-based setting.
    Alder JK; Hanumanthu VS; Strong MA; DeZern AE; Stanley SE; Takemoto CM; Danilova L; Applegate CD; Bolton SG; Mohr DW; Brodsky RA; Casella JF; Greider CW; Jackson JB; Armanios M
    Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2358-E2365. PubMed ID: 29463756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short telomeres are frequent in hereditary breast tumors and are associated with high tumor grade.
    Martinez-Delgado B; Gallardo M; Tanic M; Yanowsky K; Inglada-Perez L; Barroso A; Rodriguez-Pinilla M; Cañamero M; Blasco MA; Benitez J
    Breast Cancer Res Treat; 2013 Sep; 141(2):231-42. PubMed ID: 24036693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D Telomere Structure Analysis to DetectGenomic Instability and Cytogenetic Evolutionin Myelodysplastic Syndromes.
    Rangel-Pozzo A; Corrêa de Souza D; Schmid-Braz AT; de Azambuja AP; Ferraz-Aguiar T; Borgonovo T; Mai S
    Cells; 2019 Apr; 8(4):. PubMed ID: 30987070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere length and somatic mutations in correlation with response to immunosuppressive treatment in aplastic anaemia.
    Park HS; Park SN; Im K; Kim SM; Kim JA; Hwang SM; Lee DS
    Br J Haematol; 2017 Aug; 178(4):603-615. PubMed ID: 28699658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Telomere, telomerase and cytogenetic changes in myelodysplastic syndromes].
    Ohyashiki K; Ohyashiki JH
    Nihon Rinsho; 1998 May; 56(5):1328-32. PubMed ID: 9613146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FLT3 and NPM1 mutations in myelodysplastic syndromes: Frequency and potential value for predicting progression to acute myeloid leukemia.
    Bains A; Luthra R; Medeiros LJ; Zuo Z
    Am J Clin Pathol; 2011 Jan; 135(1):62-9. PubMed ID: 21173125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.